Bangkok Genomics Innovation PCL (BKK:BKGI)
2.060
+0.060 (3.00%)
Jun 4, 2026, 4:37 PM ICT
BKK:BKGI Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 136.99 | 221.74 | 389.93 | 165.9 | 148.34 |
Short-Term Investments | 100.88 | - | - | - | 0.02 |
Cash & Short-Term Investments | 237.86 | 221.74 | 389.93 | 165.9 | 148.36 |
Cash Growth | -37.52% | -43.13% | 135.03% | 11.83% | - |
Accounts Receivable | 287.37 | 148.06 | 71.17 | 26.96 | 31.36 |
Other Receivables | - | 18.33 | 9.05 | 2.21 | 7.5 |
Receivables | 287.37 | 166.39 | 80.22 | 29.17 | 38.86 |
Inventory | 61.39 | 36.09 | 22.09 | 10.05 | 20.27 |
Prepaid Expenses | - | 145.18 | 11.62 | 6.95 | - |
Other Current Assets | 9.9 | 10.95 | 11.06 | - | 2.9 |
Total Current Assets | 596.52 | 580.36 | 514.92 | 212.08 | 210.39 |
Property, Plant & Equipment | 80.21 | 76.74 | 78.95 | 70.4 | 82.16 |
Long-Term Investments | 0.55 | 0.59 | 0.92 | - | - |
Other Intangible Assets | 24.1 | 22.94 | 0.48 | 1.08 | 1.38 |
Long-Term Deferred Tax Assets | 1.48 | 1.27 | 0.92 | 0.76 | 0.39 |
Other Long-Term Assets | 30.71 | 19.97 | 11.41 | 8.71 | 6.26 |
Total Assets | 733.58 | 701.86 | 607.6 | 293.02 | 300.58 |
Accounts Payable | 119.47 | 82.39 | 23.76 | 11.69 | 2.49 |
Accrued Expenses | - | 14.61 | 5.99 | 6.88 | 8.5 |
Current Portion of Leases | 4.95 | 4.87 | 4.21 | 4.29 | 4.16 |
Current Income Taxes Payable | 5.01 | 1.73 | 0.27 | 0.08 | - |
Current Unearned Revenue | - | 13.15 | 5.28 | 9.32 | 1.94 |
Other Current Liabilities | 0.75 | 10.08 | 6.15 | 3.3 | 6.85 |
Total Current Liabilities | 130.17 | 126.82 | 45.68 | 35.56 | 23.94 |
Long-Term Leases | 15.34 | 16.6 | 19.79 | 19.43 | 27.47 |
Pension & Post-Retirement Benefits | 5.65 | 5.28 | 2.97 | 2.2 | 1.49 |
Total Liabilities | 151.16 | 148.7 | 68.44 | 57.2 | 52.9 |
Common Stock | 300 | 300 | 300 | 220 | 220 |
Additional Paid-In Capital | 171.21 | 171.21 | 171.21 | - | - |
Retained Earnings | 112.93 | 81.69 | 66.3 | 16.12 | 27.98 |
Comprehensive Income & Other | -1.72 | -1.68 | -0.31 | -0.31 | -0.31 |
Total Common Equity | 582.42 | 551.23 | 537.2 | 235.82 | 247.68 |
Minority Interest | 0 | 1.93 | 1.95 | - | - |
Shareholders' Equity | 582.42 | 553.15 | 539.15 | 235.82 | 247.68 |
Total Liabilities & Equity | 733.58 | 701.86 | 607.6 | 293.02 | 300.58 |
Total Debt | 20.28 | 21.47 | 24 | 23.72 | 31.63 |
Net Cash (Debt) | 217.58 | 200.27 | 365.93 | 142.18 | 116.73 |
Net Cash Growth | -39.18% | -45.27% | 157.36% | 21.80% | - |
Net Cash Per Share | 0.36 | 0.33 | 0.65 | 0.32 | 0.55 |
Filing Date Shares Outstanding | 600 | 600 | 600 | 440 | 213.88 |
Total Common Shares Outstanding | 600 | 600 | 600 | 440 | 213.88 |
Working Capital | 466.36 | 453.53 | 469.25 | 176.51 | 186.45 |
Book Value Per Share | 0.97 | 0.92 | 0.90 | 0.54 | 1.16 |
Tangible Book Value | 558.32 | 528.29 | 536.73 | 234.74 | 246.3 |
Tangible Book Value Per Share | 0.93 | 0.88 | 0.89 | 0.53 | 1.15 |
Machinery | - | 117.67 | 102.03 | 80.83 | 73.63 |